Lower risk of hypoglycaemia and greater odds for weight loss with initiation of insulin detemir compared with insulin glargine in Turkish patients with type 2 diabetes mellitus: local results of a multinational observational study

被引：0

作者：

Taner Damci

Rifat Emral

Anne Louise Svendsen

Tanzer Balkir

Jiten Vora

机构：

[1] Cerrahpasa Medical School,Department of Endocrinology, Diabetes and Metabolism

[2] Istanbul University,Department of Endocrinology and Metabolic Diseases, Faculty of Medicine

[3] Ankara University,Department of Clinical, Medical, & Regulatory Affairs

[4] Ibn-i Sina Hospital,Department of Diabetes and Endocrinology

[5] Department of Biostatistics & Epidemiology,undefined

[6] Novo Nordisk Saglik Urunleri Tic. Ltd. Sti.,undefined

[7] Royal Liverpool University Hospital,undefined

[8] the SOLVE™ study group,undefined

来源：

BMC Endocrine Disorders | / 14卷

关键词：

Insulin detemir; Insulin glargine; Basal insulin; Type 2 diabetes; Weight loss; Hypoglycaemia;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[31] Prospective observational study of insulin detemir in patients with poorly controlled type 2 diabetes mellitus initiating insulin therapy for the first time (SOLVE Study)
Orozco-Beltran, Domingo
Artota-Menendez, Sara
ATENCION PRIMARIA, 2016, 48 (02): : 95 - 101
[32] Cost-Effectiveness of Insulin Glargine and Insulin Detemir in the Basal Regimen for Naive Insulin Patients with Type 2 Diabetes Mellitus (T2DM) in Malaysia
Shafie, Asrul Akmal
Ng, Chin Hui
CLINICOECONOMICS AND OUTCOMES RESEARCH, 2020, 12 : 333 - 343
[33] Insulin Glargine versus Insulin Detemir: Glycemic Control and Insulin Dose in Type 2 Diabetes Mellitus Patients Using a Medical Record Linkage System in the Netherlands
Eland, Ingo A.
Heintjes, Edith M.
Houweling, Leanne
degrooth, Ricardo
Veneman, Thiemo F.
Bouter, K. Paul
JOURNAL OF DIABETES & METABOLISM, 2011, 2 (09)
[34] Lower risk of hypoglycaemia with insulin detemir versus NPH insulin in elderly persons with type 2 diabetes: a pooled analysis of phase 3 trials
Garber, AJ
Kim, H
Santiago, O
DIABETOLOGIA, 2005, 48 : A294 - A294
[35] Improved glycaemic control and reduced nocturnal hypoglycaemia in patients with Type 2 diabetes with morning administration of insulin glargine compared with NPH insulin
Fritsche, A
Schweitzer, MA
Häring, H
DIABETOLOGIA, 2002, 45 : A52 - A52
[36] Lower rate of hypoglycaemia with IDegLira vs insulin glargine regardless of dosing time or hypoglycaemia definition in patients with type 2 diabetes
Norwood, P.
Chen, R.
Jaeckel, E.
Lingvay, I.
Jarlov, H.
Lehmann, L.
Heller, S.
DIABETOLOGIA, 2016, 59 : S429 - S430
[37] Lower rate of hypoglycaemia with IDegLira vs insulin glargine regardless of dosing time or hypoglycaemia definition in patients with Type 2 diabetes
Norwood, P.
Chen, R.
Jaeckel, E.
Lingvay, I.
Jarlov, H.
Lehmann, L.
Heller, S.
DIABETIC MEDICINE, 2017, 34 : 142 - 143
[38] The relative cost effectiveness of insulin glargine versus detemir insulin using UK real life data in patients with type 2 diabetes mellitus
Tetlow, A. P.
McEwan, P.
Gordon, J.
DIABETOLOGIA, 2008, 51 : S406 - S406
[39] Treatment to target in Type 2 diabetes: consistent risk reduction of hypoglycaemia with basal insulin glargine as compared with NPH insulin in insulin-naive patients on oral agents.
Rosenstock, J
Riddle, M
DIABETOLOGIA, 2002, 45 : A259 - A259
[40] Novel long-acting basal insulin analogue LY2605541 significantly reduces nocturnal hypoglycaemia and fear of hypoglycaemia compared to insulin glargine in patients with type 2 diabetes mellitus
Curtis, B.
Shi, C.
DIABETOLOGIA, 2012, 55 : S392 - S392

← 1 2 3 4 5 →